End-of-day quote
Shanghai S.E.
23:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
10.91
CNY
|
-2.85%
|
|
+2.25%
|
-18.40%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,211
|
2,491
|
2,761
|
2,210
|
2,723
|
2,170
|
Enterprise Value (EV)
1 |
2,622
|
1,867
|
2,118
|
1,741
|
2,151
|
1,724
|
P/E ratio
|
18.8
x
|
69.8
x
|
11.5
x
|
18.9
x
|
27.5
x
|
-55.7
x
|
Yield
|
1.31%
|
0.42%
|
2.11%
|
1.3%
|
0.42%
|
-
|
Capitalization / Revenue
|
2.44
x
|
2.88
x
|
1.85
x
|
1.46
x
|
1.59
x
|
1.81
x
|
EV / Revenue
|
1.99
x
|
2.16
x
|
1.42
x
|
1.15
x
|
1.26
x
|
1.44
x
|
EV / EBITDA
|
13.2
x
|
28.4
x
|
6.88
x
|
9.52
x
|
13.2
x
|
46.3
x
|
EV / FCF
|
68.6
x
|
5.29
x
|
45.7
x
|
-7.48
x
|
-67.2
x
|
10,677
x
|
FCF Yield
|
1.46%
|
18.9%
|
2.19%
|
-13.4%
|
-1.49%
|
0.01%
|
Price to Book
|
2.9
x
|
2.26
x
|
2.06
x
|
1.56
x
|
1.7
x
|
1.44
x
|
Nbr of stocks (in thousands)
|
156,800
|
162,690
|
162,727
|
162,349
|
162,294
|
162,312
|
Reference price
2 |
20.48
|
15.31
|
16.96
|
13.61
|
16.78
|
13.37
|
Announcement Date
|
25/04/19
|
26/04/20
|
30/03/21
|
06/04/22
|
28/04/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,317
|
865.8
|
1,494
|
1,518
|
1,709
|
1,196
|
EBITDA
1 |
198.3
|
65.72
|
307.9
|
182.8
|
163.2
|
37.26
|
EBIT
1 |
161.7
|
22.41
|
258.4
|
119.2
|
98.6
|
-34.52
|
Operating Margin
|
12.28%
|
2.59%
|
17.29%
|
7.85%
|
5.77%
|
-2.89%
|
Earnings before Tax (EBT)
1 |
162.9
|
41.05
|
274.8
|
132.2
|
100.5
|
-47.78
|
Net income
1 |
138.8
|
34.76
|
235.7
|
114.7
|
99.23
|
-39.16
|
Net margin
|
10.54%
|
4.01%
|
15.77%
|
7.56%
|
5.81%
|
-3.27%
|
EPS
2 |
1.092
|
0.2194
|
1.471
|
0.7200
|
0.6100
|
-0.2400
|
Free Cash Flow
1 |
38.22
|
353.1
|
46.37
|
-232.7
|
-32.03
|
0.1615
|
FCF margin
|
2.9%
|
40.79%
|
3.1%
|
-15.33%
|
-1.87%
|
0.01%
|
FCF Conversion (EBITDA)
|
19.27%
|
537.28%
|
15.06%
|
-
|
-
|
0.43%
|
FCF Conversion (Net income)
|
27.54%
|
1,015.86%
|
19.68%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2679
|
0.0643
|
0.3571
|
0.1770
|
0.0700
|
-
|
Announcement Date
|
25/04/19
|
26/04/20
|
30/03/21
|
06/04/22
|
28/04/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
590
|
624
|
643
|
469
|
572
|
446
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
38.2
|
353
|
46.4
|
-233
|
-32
|
0.16
|
ROE (net income / shareholders' equity)
|
16.8%
|
3.14%
|
19.3%
|
8.31%
|
6.56%
|
-2.56%
|
ROA (Net income/ Total Assets)
|
7.72%
|
0.92%
|
9.13%
|
3.74%
|
2.64%
|
-0.81%
|
Assets
1 |
1,799
|
3,761
|
2,580
|
3,071
|
3,752
|
4,863
|
Book Value Per Share
2 |
7.070
|
6.770
|
8.230
|
8.750
|
9.860
|
9.290
|
Cash Flow per Share
2 |
2.260
|
2.310
|
3.960
|
2.250
|
4.340
|
5.060
|
Capex
1 |
77.3
|
89.3
|
137
|
140
|
164
|
140
|
Capex / Sales
|
5.87%
|
10.32%
|
9.16%
|
9.25%
|
9.62%
|
11.69%
|
Announcement Date
|
25/04/19
|
26/04/20
|
30/03/21
|
06/04/22
|
28/04/23
|
25/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.40% | 250M | | +3.34% | 3.67B | | -20.60% | 2.14B | | -6.63% | 1.99B | | +5.93% | 1.94B | | +0.77% | 1.72B | | +5.69% | 1.21B | | -18.21% | 1.08B | | -2.47% | 1.01B | | -8.04% | 906M |
Pesticide
|